Мэриленд Университетінің Медицина мектебі

Medical school of the University of Maryland Baltimore

The University of Maryland School of Medicine (abbreviated UMSOM), located in Baltimore City, Maryland, U. S., is the medical school of the University of Maryland, Baltimore and is affiliated with the University of Maryland Medical Center and Medical System. In addition to an degree, the UMB SOM offers PhD programs through the Graduate Program in Life Sciences. It also offers several joint degree programs: a Medical Scientist Training Program (MSTP) MD/PhD, a joint MD/DDS (Doctor of Dental Surgery), the MD/MPH (Master of Public Health) program, and the PhD/DPT (Doctor of Physical Therapy). The University of Maryland School of Medicine was ranked 15th in U. S. News & World Reports 2023 rankings of "Best Medical Schools: Primary Care", and 29th in "Best Medical Schools: Research". In 2013, the school offered admission to 6.3% of applicants. Since August 1, 2022, the Dean of Medicine has been Dr. Mark T. Gladwin, MD.

Chartered as the College of Medicine of Maryland in December 1807, and the only public medical school in the U. S. at the time. It is the fifth oldest medical school in the country after the medicals schools at Columbia University (established May 1807), Dartmouth College (1798), Harvard University (1782), and the University of Pennsylvania (1765). A group of physicians made several short lived attempts at starting medical schools around the turn of the 19th century, and were finally successful in 1807 when the Maryland state legislature passed the Medical College Bill, authorizing the formation the College of Medicine of Maryland. In 1812 it was rechartered as the University of Maryland School of Medicine. In the 1950s, the building was named after John Beale Davidge, one of the founders and the first dean of the College of Medicine of Maryland. Beginning in 1938, the school instituted antisemitic quotas limiting Jewish applications to 14%. The school also limited the number of local applicants in an attempt to reduce the number of Jewish students, given the large number of Jewish people living in the Maryland suburban communities of Prince George's and Montgomery counties. The anti Jewish quota system was abandoned in 1950.

The Institute of Human Virology (IHV) was formed in 1996 as a research institute of the University of Maryland School of Medicine, headed and co founded by Robert Gallo, the only recipient of two Lasker Awards for the discovery of the first human retrovirus, and the discovery of HIV as the cause of AIDS. IHV operates in a dedicated building on the UMSOM campus next to the University of Maryland Medical Center as a partnership between the State of Maryland, the City of Baltimore, the University System of Maryland and the University of Maryland Medical System.

Launched in 2007, the Institute for Genome Sciences (IGS) is a genomics research center at the University of Maryland School of Medicine. IGS investigators use genomic and bioinformatic tools to research genome function in health and diseases and work in interdisciplinary collaborations with biomedical investigators. IGS is led by Dr. Claire M. Fraser Liggett. Research areas include: Bioinformatics, Cancer Genomics, Functional Genomics, Human Genetic Variation, Infectious Diseases, Organismal Diversity and Evolution, Human Microbiome Project, Plant Genomics, and Microbial Community Ecology. Investigators at IGS work on Disease Ontology research, the Data Analysis and Coordination Center (DACC) for HMP, and other grants. IGS is one of the Genome Sequencing Center for Infectious Diseases (GSCID) centers designated by NIAID.

The Institute for Global Health (IGH) was established in 2015. The IGH develops new and improved ways of diagnosing, preventing, treating, controlling and eradicating diseases of global impact. Such diseases include malaria, Ebola and vaccine preventable infectious diseases such as measles. The IGH includes the Center for Vaccine Development (CVD) and the Division of Malaria Research.

The MPRC was established on the grounds of Spring Grove Hospital as a result of public interest in the research pioneered there on the use of the psychedelic compound LSD in Schizophrenia research. The first of this series of experiments, which came to be known as the Spring Grove Experiment, began in 1955 in cottage 13 of the hospital grounds. The study was largely conducted by the members of the Research Unit of Spring Grove State Hospital, and became the largest study on psychedelic drugs in psychiatric research. After the study gained media publicity, research funding was made available and a new building was constructed on the north side of the hospital grounds to house MPRC, a division of the department of Psychiatry of the University of Maryland School of Medicine. Currently, MPRC hosts over 20 clinical and basic research faculty that form its core research program into psychiatric disease. MPRC is also the editorial seat for the Schizophrenia Bulletin, a peer reviewed medical journal dedicated to schizophrenia research.

The Department of Medical and Research Technology (DMRT) offers a graduate program and a categorical certificate program and the School of Medicine's only undergraduate program. It is the largest accredited medical technology program in the state of Maryland. The Physical Therapy and Rehabilitation Science (PTRS) department, established in 1956, offers a Doctor of Physical Therapy (DPT) degree, which is a 3 year program, a PhD in rehabilitation sciences and a dual DPT/PhD program. In the 2010 edition of U. S. News & World Report physical therapy school rankings, UMB PTRS ranked 15th in the nation.